Application Detail

Description of Medical Service

Pre-term preeclampsia risk assessment performed using a multi-variate testing algorithm at 11-13⁺⁶ weeks’ gestation. The algorithm includes:

• Clinical measurement of maternal Mean Arterial Pressure
• Biochemical measurement of maternal serum concentration of Placental Growth Factor; and
• Ultrasound assessment of uterine perfusion (Doppler measurement of uterine artery pulsatility index).

Description of Medical Condition

Preeclampsia is a pregnancy-specific condition resulting in maternal hypertension (high blood pressure) and multisystem dysfunction. Once preeclampsia develops, it becomes progressively worse until infant delivery. Preterm preeclampsia is a more severe form of diseasde with earlier onset that causes more cardiovascular morbidity for mothers in later life. The preeclamptic fetus is often growth restricted. Planned pre-term birth puts the surviving fetus at substantially increased risk of death or lifelong morbidity.

Reason for Application

New MBS item

Medical Service Type

Investigative medical technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Form

Application Form (PDF 1152 KB)
Application Form (Word 120 KB)

Consultation Survey

Consultation Survey (PDF 688 KB
Consultation Survey (Word 72 KB)

PASC Consultation
Consultation Closed

MSAC Consultation
MSAC consultation input must be received by no later than Friday, 6 October 2023 for it to be considered by MSAC at its November 2023 meeting.

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

PICO Confirmation (PDF 1073 KB)
PICO Confirmation (Word 849 KB)

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

13-14 April 2022

ESC

5-6 October 2023

MSAC

23-24 November 2023